- Hong Kong
- /
- Medical Equipment
- /
- SEHK:1066
Shandong Weigao Group Medical Polymer First Half 2024 Earnings: Revenues Disappoint
Shandong Weigao Group Medical Polymer (HKG:1066) First Half 2024 Results
Key Financial Results
- Revenue: CN¥6.64b (down 3.8% from 1H 2023).
- Net income: CN¥1.11b (down 7.5% from 1H 2023).
- Profit margin: 17% (in line with 1H 2023).
- EPS: CN¥0.25 (down from CN¥0.27 in 1H 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Shandong Weigao Group Medical Polymer Earnings Insights
Looking ahead, revenue is forecast to grow 8.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Medical Equipment industry in Hong Kong.
Performance of the Hong Kong Medical Equipment industry.
The company's shares are up 6.4% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 1 warning sign for Shandong Weigao Group Medical Polymer that you need to be mindful of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:1066
Shandong Weigao Group Medical Polymer
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.
Flawless balance sheet, undervalued and pays a dividend.